CTKB — CYTEK BIOSCIENCES INC

Ownership history in Numerai GP LLC  ·  3 quarters on record

This page tracks every 13F SEC filing in which Numerai GP LLC reported a position in CYTEK BIOSCIENCES INC (CTKB). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.21% (2025 Q2)
Avg. % of fund
0.12%
First filed
2025 Q2
Last filed
2025 Q4
Quarters held
3
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q4 ADDED 186,764 +80,269 +75.4% 0.11% $943K $5.05
2025 Q3 REDUCED 106,495 -315,823 -74.8% 0.05% $370K $3.47
2025 Q2 INITIATED 422,318 — — 0.21% $1.4M $3.40
% of Fund (quarterly)    CTKB price (monthly, adj. close)

Other funds also holding CTKB

As of 2025 Q4 — sorted by position size

Topline Capital Management, LLC 3.4% HHLR ADVISORS, LTD. 3Y 7Y 1.08% BROWN CAPITAL MANAGEMENT LLC 3Y 7Y 0.86% ROYCE & ASSOCIATES LP 3Y 7Y 0.09% Dynamic Technology Lab Private Ltd 3Y 7Y 0.05% PDT Partners, LLC 3Y 7Y 0.03% Boston Partners 3Y 7Y 0.03% AXQ CAPITAL, LP 3Y 0.02% MILLENNIUM MANAGEMENT LLC 3Y 7Y 0.01% HRT FINANCIAL LP 3Y 7Y 0.01%
← Back to Numerai GP LLC Holdings